Cargando…
Profile of sapacitabine: potential for the treatment of newly diagnosed acute myeloid leukemia in elderly patients
Acute myeloid leukemia (AML) is a hematopoietic stem cell disorder that affects approximately 14,000 persons each year in the US. AML occurs at all ages but the incidence increases with age with the median age at diagnosis being 67 years. Advances in the treatment of AML over the past decades have l...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4018315/ https://www.ncbi.nlm.nih.gov/pubmed/24851045 http://dx.doi.org/10.2147/CIA.S39558 |